CeriBell, Inc. (CBLL)
NASDAQ: CBLL · Real-Time Price · USD
19.99
-0.23 (-1.14%)
Feb 23, 2026, 4:00 PM EST - Market closed
CeriBell Revenue
CeriBell had revenue of $22.59M in the quarter ending September 30, 2025, with 31.37% growth. This brings the company's revenue in the last twelve months to $82.81M, up 37.93% year-over-year. In the year 2024, CeriBell had annual revenue of $65.44M with 44.71% growth.
Revenue (ttm)
$82.81M
Revenue Growth
+37.93%
P/S Ratio
8.95
Revenue / Employee
$294,708
Employees
281
Market Cap
741.54M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 65.44M | 20.22M | 44.71% |
| Dec 31, 2023 | 45.23M | 19.30M | 74.47% |
| Dec 31, 2022 | 25.92M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionCBLL News
- 5 days ago - Ceribell to Participate in Upcoming March Investor Conferences - GlobeNewsWire
- 13 days ago - Ceribell to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026 - GlobeNewsWire
- 6 weeks ago - CeriBell, Inc. (CBLL) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 7 weeks ago - Ceribell Receives FDA Breakthrough Device Designation for LVO Stroke Detection and Monitoring Solution - GlobeNewsWire
- 7 weeks ago - Ceribell to Participate in the 44th Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 2 months ago - Ceribell Receives FDA 510(k) Clearance for First-of-its-Kind Delirium Monitoring Solution - GlobeNewsWire
- 3 months ago - Ceribell Receives FDA 510(k) Clearance for Use of ClarityⓇ Algorithm for Neonates - GlobeNewsWire
- 3 months ago - Ceribell to Participate in the Piper Sandler 37th Annual Healthcare Conference - GlobeNewsWire